Literature DB >> 23750457

The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.

Sun Young Oh1, Erik H Knelson, Gerard C Blobe, Karthikeyan Mythreye.   

Abstract

Cell adhesion and migration are tightly controlled by regulated changes in the actin cytoskeleton. Previously we reported that the TGFβ (transforming growth factor β) superfamily co-receptor, TβRIII (type III TGFβ receptor; also known as βglycan), regulates cell adhesion, migration and invasion, and suppresses cancer progression, in part, through activation of the small GTPase Cdc42 (cell division cycle 42), and Cdc42-dependent alterations to the actin cytoskeleton. In the present study we demonstrate that TβRIII specifically promotes filopodial formation and extension in MCF10A and HMEC (human mammary epithelial cell) mammary epithelial cells. Mechanistically, cell-surface TβRIII and Cdc42 co-localize to filopodial structures and co-complex in a β-arrestin2-dependent, and a TβRI/TβRII-independent manner. The β-arrestin2-mediated interaction between TβRIII and Cdc42 increases complex formation between the Cdc42 effectors IRSp53 with N-WASP (neuronal Wiskott-Aldrich syndrome protein) to increase filopodial formation. We demonstrate a function link between filopodial structures and epithelial cell adhesion as regulated by the TβRIII-Cdc42 interaction. The present studies identify TβRIII as a novel regulator of IRSp53/N-WASP via Cdc42 to regulate filopodial formation and cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23750457      PMCID: PMC4082962          DOI: 10.1042/BJ20121701

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes.

Authors:  Kenneth W Finnson; Betty Y Y Tam; Kai Liu; Anne Marcoux; Pierre Lepage; Stephane Roy; Albane A Bizet; Anie Philip
Journal:  FASEB J       Date:  2006-06-05       Impact factor: 5.191

2.  ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis.

Authors:  J R Howe; J L Haidle; G Lal; J Bair; C Song; B Pechman; S Chinnathambi; H T Lynch
Journal:  Clin Genet       Date:  2007-01       Impact factor: 4.438

3.  Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.

Authors:  Kelly J Gordon; Mei Dong; Elizabeth M Chislock; Timothy A Fields; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2007-11-13       Impact factor: 4.944

4.  Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart.

Authors:  C B Brown; A S Boyer; R B Runyan; J V Barnett
Journal:  Science       Date:  1999-03-26       Impact factor: 47.728

5.  Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer.

Authors:  Takehiko Ochiumi; Yasuhiko Kitadai; Shinji Tanaka; Morihisa Akagi; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

6.  Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A.

Authors:  Masashi Narazaki; Giovanna Tosato
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

7.  Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice.

Authors:  Annette Düwel; Nélida Eleno; Mirjana Jerkic; Miguel Arevalo; Juan P Bolaños; Carmelo Bernabeu; Jose M López-Novoa
Journal:  Tumour Biol       Date:  2006-11-14

8.  The type III TGF-beta receptor suppresses breast cancer progression.

Authors:  Mei Dong; Tam How; Kellye C Kirkbride; Kelly J Gordon; Jason D Lee; Nadine Hempel; Patrick Kelly; Benjamin J Moeller; Jeffrey R Marks; Gerard C Blobe
Journal:  J Clin Invest       Date:  2006-12-07       Impact factor: 14.808

9.  Loss of betaglycan expression in ovarian cancer: role in motility and invasion.

Authors:  Nadine Hempel; Tam How; Mei Dong; Susan K Murphy; Timothy A Fields; Gerard C Blobe
Journal:  Cancer Res       Date:  2007-05-23       Impact factor: 12.701

10.  Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells.

Authors:  Maddy Parsons; James Monypenny; Simon M Ameer-Beg; Thomas H Millard; Laura M Machesky; Marion Peter; Melanie D Keppler; Giampietro Schiavo; Rose Watson; Jonathan Chernoff; Daniel Zicha; Borivoj Vojnovic; Tony Ng
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more
  6 in total

1.  Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.

Authors:  B O Sun; Yantian Fang; Zhenyang Li; Zongyou Chen; Jianbin Xiang
Journal:  Biomed Rep       Date:  2015-07-27

2.  Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling.

Authors:  Laura M Jenkins; Priyanka Singh; Archana Varadaraj; Nam Y Lee; Shreya Shah; Haley V Flores; Kathleen O'Connell; Karthikeyan Mythreye
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

Review 3.  Dually modified transmembrane proteoglycans in development and disease.

Authors:  Laura M Jenkins; Ben Horst; Carly L Lancaster; Karthikeyan Mythreye
Journal:  Cytokine Growth Factor Rev       Date:  2017-12-22       Impact factor: 17.660

4.  Dynamic filopodia are required for chemokine-dependent intracellular polarization during guided cell migration in vivo.

Authors:  Dana Meyen; Katsiaryna Tarbashevich; Torsten U Banisch; Carolina Wittwer; Michal Reichman-Fried; Benoît Maugis; Cecilia Grimaldi; Esther-Maria Messerschmidt; Erez Raz
Journal:  Elife       Date:  2015-04-15       Impact factor: 8.140

5.  GRHL3 binding and enhancers rearrange as epidermal keratinocytes transition between functional states.

Authors:  Rachel Herndon Klein; Ziguang Lin; Amelia Soto Hopkin; William Gordon; Lam C Tsoi; Yun Liang; Johann E Gudjonsson; Bogi Andersen
Journal:  PLoS Genet       Date:  2017-04-26       Impact factor: 5.917

Review 6.  TGFβ signaling networks in ovarian cancer progression and plasticity.

Authors:  Asha Kumari; Zainab Shonibare; Mehri Monavarian; Rebecca C Arend; Nam Y Lee; Gareth J Inman; Karthikeyan Mythreye
Journal:  Clin Exp Metastasis       Date:  2021-02-15       Impact factor: 5.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.